Laboratorio de Parasitología Molecular, IIB-INTECH, CONICET-UNSAM, Av. Intendente Marino Km. 8.2, C.C 164, (B7130IIWA), Chascomús, Prov. Buenos Aires, Argentina.
Int J Biol Macromol. 2012 Apr 1;50(3):725-33. doi: 10.1016/j.ijbiomac.2011.12.012. Epub 2011 Dec 23.
Toxoplasma gondii is an obligate intracellular protozoan parasite in which 36 predicted Hsp40 family members were identified by searching the T. gondii genome. The predicted protein sequence from the gene ID TGME49_065310 showed an amino acid sequence and domain structure similar to Saccharomyces cerevisiae Sis1. TgSis1 did not show differences in its expression profile during alkaline stress by microarray analysis. Furthermore, TgSis1 showed to be a cytosolic Hsp40 which co-immunoprecipitated with T. gondii Hsp70 and Hsp90. Structural modeling of the TgSis1 peptide binding fragment revealed structural and electrostatic properties different from the experimental model of human Sis1-like protein (Hdj1). Based on these differences; we propose that TgSis1 may be a potentially attractive drug target for developing a novel anti-T. gondii therapy.
刚地弓形虫是一种专性细胞内原生动物寄生虫,通过搜索刚地弓形虫基因组,鉴定出 36 种预测的 HSP40 家族成员。从基因 ID TGME49_065310 预测的蛋白质序列显示出与酿酒酵母 Sis1 相似的氨基酸序列和结构域结构。通过微阵列分析,TgSis1 在碱性应激过程中的表达谱没有差异。此外,TgSis1 显示为一种胞质 HSP40,与刚地弓形虫的 HSP70 和 HSP90 共免疫沉淀。TgSis1 肽结合片段的结构建模揭示了与人类 Sis1 样蛋白(Hdj1)实验模型不同的结构和静电特性。基于这些差异,我们提出 TgSis1 可能是一种有吸引力的药物靶点,可用于开发新型抗刚地弓形虫治疗方法。